science semaglutide & GLP-1: Science-Backed Weight Loss Guide (2024) SkinnyRx | Compounded Sublingual Semaglutide
Description
It can be seen from the figure that the weight had significantly regained in 8 weeks after treatment discontinuation, and showed a rising trend within 12 weeks and 20 weeks after treatment discontinuation, and then the weight regain gradually stabilized

The trial includes seven treatment groups some receiving combinations of the three medications, others a placebo allowing researchers to identify which approach is most effective

Its almost entirely water weight, that is

They propose based on rodent and monkey studies that this kind of molecule, when administered at high enough doses, may result in weight loss comparable to the weight loss seen with drugs that include GLP-1 as a target, and without the tolerability issues like nausea and vomiting that often come with the approved treatments, according to a peer-reviewed draft paper published this week
These are based on animal studies only, where activation of GLP-1 receptors led to calcitonin release and C-cell hyperplasia
